Federal Register / Vol. 62, No. 9 / Tuesday, January 14, 1997 / Notices 1893

took place in Dakar, Senegal, January 6–

9.

In accordance with the provisions of

section 552b(c)(4) and 552b(c)(6), Title

5, United States Code and section 10(d)

of Public Law 92–463, as amended, the

meeting will be closed to the public

from 1:00 p.m. to adjournment for the

review of applications for awards under

the Senior International Fellowship

Program and the International Research

Fellowship Program; and the Fogarty

International Research Collaboration

Awards and HIC, AIDS and Related

Illnesses Collaboration Awards.

Paula Cohen, Committee Management

Officer, Fogarty International Center,

National Institutes of Health, Building

31, Room B2C08, 31 Center Dr, MSC

2220, Bethesda, Maryland 20892–2220,

telephone: 301–496–1491, will provide

a summary of the meeting and a roster

of the committee members upon

request.

Irene Edwards, Executive Secretary,

Fogarty International Center Advisory

Board, Building 31, Room B2C08,

telephone: 301–496–1491, will provide

substantive program information.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Cohen at least 2 weeks in

advance of the meeting.

(Catalog of Federal Domestic Assistance

Program No. 93.989, Senior International

Awards Program)

Dated: January 9, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–852 Filed 1–13–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meeting

Pursuant to the Federal Advisory

Committee Act, as amended (5 U.S.C.

Appendix 2), notice is hereby given of

a meeting of the President’s Cancer

Panel. This meeting will be closed in

accordance with the provisions of

section 552b(c)(9)(B), Title 5 U.S.C., for

discussion and preparation of the

Annual Report of the Chair to the

President for 1996. These discussions

could disclose information, the

premature disclosure of which would be

likely to significantly frustrate

implementation of proposed action the

Panel may plan to take.

Cynthia Morgan, Committee

Management Specialist, National Cancer

Institute, Executive Plaza North, Room

630E, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405 (301/

496–5708) will provide a copy of the

roster of committee members upon

request. Other information pertaining to

the meeting may be obtained from the

contact person indicated below.

Committee Name: President’s Cancer

Panel.

Date: February 4, 1997.

Place: Hyatt Regency Bethesda, 1 Bethesda

Metro Center, Bethesda, MD 20814.

Closed: 9:30 a.m. to 4:00 p.m.

Agenda: Discusson and preparation of the

Annual Report of the Chair to the President.

Contact Person: Maureen O. Wilson, Ph.D.,

Executive Secretary, National Cancer

Institute, Building 31, Room 4A48, Bethesda,

MD 20892, Telephone: (301) 496–1148.

Dated: January 7, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–851 Filed 1–13–97; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Cancer Institute Special

Emphasis Panel (SEP) meetings:

Name of SEP: Metabolic Imaging of Cancer

and Its Response to Therapy.

Date: January 26–28, 1997.

Time: January 26–7 p.m., January 26–28—

8 a.m.

Place: The Madison A Renaissance Hotel,

515 Madison Street, Seattle, Washington

98104.

Contact Person: Ray Bramhall, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 636, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–3428.

Purpose/Agenda: To review, discuss and

evaluate individual grant applications.

This notice is being published less

than 15 days prior to the above meeting

due to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

Name of SEP: Colorectal Cancer Screening:

A Cancer Control Opportunity.

Date: February 3–5, 1997.

Time: February 3–7 p.m., February 4–5—

8 a.m.

Place: The Double Tree Hotel, 10760

Wilshire Boulevard, Los Angeles, California

90034.

Contact Person: Ray Bramhall, Ph.D.,

Scientific Review Administrator, National

Cancer Institute, NIH, Executive Plaza North,

Room 636, 6130 Executive Boulevard, MSC

7405, Bethesda, MD 20892–7405, Telephone:

301/496–3428.

Purpose/Agenda: To review, discuss and

evaluate individual grant applications.

The meetings will be closed in

accordance with the provisions set forth

in sections 552b(c)(4) and 552b(c)(6),

Title 5, U.S.C. Applications and/or

proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: January 8, 1997.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–857 Filed 1–13–97; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meetings:

Name of SEP: Maintenance of a Biological

Specimen Repository.

Date: February 4, 1997.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Diane M. Reid, M.D., Two

Rockledge Center, Room 7182, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

contract proposals.

This notice is being published less

than fifteen days prior to the meeting

due to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

Name of SEP: Comprehensive Sickle Cell

Center.

Date: May 12–14, 1997.

Time: 8:00 a.m.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Deborah P. Beebe, Ph.D.,

Two Rockledge Center, Room 7178, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0270.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth

in sections 552b(c)(4) and 552b(c)(6),

Title 5, U.S.C. Applications and/or

proposals and the discussions could